Navigation Links
'Protected Classes' Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
Date:7/18/2012

WASHINGTON, July 18, 2012 /PRNewswire-USNewswire/ -- Imposing a federal "protected classes" prescription drug mandate on individual and small employer plans would raise premiums, grant drug companies unlimited pricing power, and create strong opposition from small businesses, the Pharmaceutical Care Management Association (PCMA) said today.  The Centers for Medicare & Medicaid Services (CMS) says a similar mandate is dramatically increasing costs in Medicare Part D.

In the commercial market, employers and unions negotiate discounts from drug companies in exchange for covering their drugs.  This reduces premiums and offers manufacturers a greater marketplace.  To simply force plans to cover expensive brands – regardless of price – would eliminate manufacturers' incentives to offer discounts.  The result would be higher costs and virtually unchecked pricing power for drug companies.

Unfortunately, "protected classes" regulations have already taken their toll on Medicare Part D.  CMS estimates that they will increase costs by $4.2 billion.  There is no corresponding evidence that Medicare beneficiaries' health or access to care has improved as a result.

In a recent survey, 66% of small employers say "cost" is their top consideration when considering health benefits.  Imposing "protected classes" would not only undermine affordability but also contradict the Department of Health and Human Services' (HHS) pronouncement that states can design benefits like those of popular, high-performing plans that local employers already use.  No such plans are governed by "protected classes" regulations.

"These 'protected class' mandates would grant drug companies unlimited pricing power and make coverage less affordable for individuals and small businesses.  Small businesses shouldn't have to choose between a bloated Cadillac plan and no plan at all.  They want access to affordable plans that offer broad coverage, promote generics, and reduce brand name drug costs," said PCMA President and CEO Mark Merritt.

The poll of small business owners and human resource managers (who represent the companies directly impacted by the upcoming Essential Health Benefits regulations) found that:

  • Small businesses want low-cost coverage options, not mandatory "Cadillac coverage." Their top priorities are low pharmacy costs for their business (66 percent) and lower out-of-pocket costs for their employees (39 percent). Given a choice, they prefer basic coverage with lower premiums (71 percent) to expanded coverage with higher premiums (19 percent).
  • Small businesses that provide drug benefits are overwhelmingly satisfied with the benefits that they are able to offer. By an 86 to 11 percent margin, small businesses that provide drug benefits are satisfied with those benefits.
  • Seventy-four percent oppose mandating across-the-board, low co-pays for high-priced drugs. By a 2-1 margin, small businesses think it would be better to require drug companies to offer case-by-case price discounts to those in need.
  • Small businesses want access to plans that encourage delivery of prescription drugs through the mail. 79 percent say it is a good idea to "allow plans to offer discounts that encourage employees to get prescriptions by mail."

The survey echoes concerns outlined by the Essential Health Benefits Coalition (an employer led coalition comprised of the National Federation of Independent Business, the National Retail Federation, and others) and Administration policy that commercial practice would be the benchmark for essential health benefits for prescription drugs.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve
affordability and quality of care through the use of electronic prescribing (e-prescribing),
generic alternatives, mail-service pharmacies, and other innovative tools for 216 million Americans.

Follow PCMA on Twitter


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
2. President Obama Signs Landmark Accessible Prescription Drug Label Bill
3. New Video, Website Help Health Plan Sponsors, Patients and Policy Makers Maximize Prescription Drug Benefits, Reduce Wasteful Spending
4. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
5. Partnership Aims to Prevent Students from Misusing Prescription Drugs
6. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
7. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
8. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
9. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
10. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
11. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , Net Sales of $1.90 billion represent ... prior year period, and an increase of 1.2% on an ... for the first quarter were $0.52 reported, a decrease of ... increase of 29.9% over the prior year period , ... for 2016 Zimmer Biomet Holdings, Inc. (NYSE and ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... India , April 28, 2016 ... Pipeline Review, H1 2016" is a report that ... and helps strengthen R&D pipelines by identifying new ... products. Company Profiles discussed in this ... Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded ... to confront and deal with these stressors is to adopt a more healthful diet, ... for you. Risa Groux, a certified Holistic Nutritionist and the creator of the Newport ...
(Date:4/29/2016)... VA (PRWEB) , ... April 29, 2016 , ... ... with student loans more flexibility in repaying their loans, more information about their ... a time when total outstanding student loan debt, including federal and private loans, ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Spine Team Texas, ... is proud to announce one of their physicians has been invited to be a ... (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free ... is pleased to announce the launch of the GFCP Scoop in ... more. The purpose of the GFCP Scoop site is to keep ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Reltok ... devices and products for the head and neck/ear, nose and throat specialty, has added ... , The KOTLER NASAL AIRWAY™ is a newly patented safety device secured ...
Breaking Medicine News(10 mins):